ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Nationwide Children's Hospital Phase I/II Infrastructure||Research Institute at Nationwide Children's Hospital / Sarah O'Brien, MD and Timothy Cripe, MD, PhD||Phase I/II Infrastructure Grants||2013||Ohio|
|Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant||University of Pittsburgh / Jean Tersak, MD||Phase I/II Infrastructure Grants||2013||Pennsylvania|
|Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2013||Washington|
|The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center||Case Western Reserve University / Letterio, John MD & Matloub, Yousif MD||Phase I/II Infrastructure Grants||2013||Ohio|
|Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers||Dana-Farber Cancer Institute / Charles Roberts, MD, PhD||Innovation Grants||2013||Massachusetts|
|Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD||Innovation Grants||2013||Massachusetts|
|Genetic Alterations in Intramedullary Spinal Cord Tumors||The Johns Hopkins University School of Medicine / George Jallo, MD||Innovation Grants||2013||Maryland|
|Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma||Columbia University Medical Center / Darrell Yamashiro, MD, PhD||Innovation Grants||2013||New York|
|Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma||Duke University / Corinne Mary Linardic, MD, PhD||Innovation Grants||2013||North Carolina|
|Nanoparticle Delivery of Therapeutic Agents in Neuroblastomas||Children's Hospital of Philadelphia / Garrett M. Brodeur, MD||Innovation Grants||2013||Pennsylvania|